Evidence map›Paper›PMID 42188289›Full record

ReviewMarine drugs2026

Francisco Cen-Pacheco, Ana R Díaz-Marrero, José J Fernández

Abstract readReview
In one paragraph

Review in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Laurinterol, the MainMarine drugs · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francisco Cen-PachecoFacultad de Bioanálisis, Campus-Veracruz, Universidad Veracruzana, Veracruz 91700, Mexico.ORCID 0000-0001-8506-2435
Ana R Díaz-MarreroInstituto de Productos Naturales y Agrobiología (IPNA), Consejo Superior de Investigaciones Científicas (CSIC), Avenida Astrofísico Francisco Sánchez 3, 38206 La Laguna, Spain.ORCID 0000-0002-8886-7519
José J FernándezBiotecnología Marina, IUBO-ULL, Unidad Asociada al IPNA-CSIC, 38206 La Laguna, Spain.ORCID 0000-0002-0805-8317

Funding

Gobierno de Canarias ProID2024010033 (BIMICMAR)Gobierno de Canarias PROMOTUR_SP3
6 · The paper itself

Abstract

Dehydrothyrsiferol (DT), a brominated oxasqualenoid from the red alga

Indexed as

Aquatic OrganismsLaurenciaAnimalsAntineoplastic AgentsHumansSecondary MetabolismAntineoplastic Agentsdehydrothyrsiferoldrug discoveryLaurencia viridisoxasqualenoidsSmart Secondary Metabolites

Identifiers

PMID42188289
PMCPMC13208329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.